The Reaction Project

HONcode

This site complies with the HONcode standard for trust worthy health information:
verify here.

Affiliations

REACTION is affilliated with these programs and organisations:

REACTION is delivering better and more efficient healthcare services in Europe, thus supporting the Commissions activities in ICT for Health: eHealth.

The REACTION platform allows for the creation of inclusive applications with accessibility for all. The project supports the Commissions campaign: eInclusion - be part of it!

Sign In

Forgotten your password?
Request a new one here.

Facts

The REACTION project is a 4-year project started in 2010. It is partly funded by the European Commission under the 7th Framework Programme in the area of Personal Health Systems under Grant Agreement no. 248590

Impressum

Privacy

Previous Newsletters

Read previous issues of our newsletter here:

April 2014
August 2013
June 2012
August 2011
April 2011
November 2010

Most Read...

Articles

In-hospital saf...	185169
Reaction in the...	111411
Project overview	104809
Medical background	104031
Project methodo...	78567

News

Research award ...	56048
IST-Africa Call...	52014
REACTION at one...	50035
REACTION videos...	48506
REACTION online...	47150

Popular Downloads

REACTION brochure	30121
Design of a mobil...	13007
D9-4 Healthcare e...	11056
D9-2 Regulatory f...	8387
2_Regulatory Fram...	6506

eHealth at Facebook

Join the discussion on EC eHealth at Facebook!

Oh no! Where's the JavaScript?
Your Web browser does not have JavaScript enabled or does not support JavaScript. Please enable JavaScript on your Web browser to properly view this Web site, or upgrade to a Web browser that does support JavaScript.

Downloads: In vivo evaluation of a chip based near infrared sensor for continuous glucose monitoring

Downloads Home > Journal papers > In vivo evaluation of a chip based near infrared sensor for continuous glucose monitoring

In vivo evaluation of a chip based near infrared sensor for continuous glucose monitoring

Abstract: In this paper we describe the concept and in vivo results of a minimally invasive, chip-based near infrared (NIR) sensor, combined with microdialysis, for continuous glucose monitoring. The sensor principle is based on difference absorption spectroscopy in selected wavelength bands of the near infrared spectrum (1300 nm, 1450 nm, and 1550 nm) in the 1st overtone band. In vitro measurements revealed a linear relationship between glucose concentration and the integrated difference spectroscopy signal with a coefficient of determination of 99% in the concentration range of 0–400 mg/dl. The absolute error in this case is about 5 mg/dl, corresponding to a relative error of about 5% for glucose concentrations larger than 50 mg/dl and about 12% in the hypoglycemic range (<50 mg/dl). In vivo measurements on 10 patients showed that the NIR-CGM sensor data reflects the blood reference values adequately, if a proper calibration and a signal drift correction is applied. The mean MARE (mean absolute relative error) value taken over all patient data is 13.8%. The best achieved MARE value is at 4.8%, whereas the worst lies at 25.8%, leading to a standard deviation of 5.5%.